GlassScriptPhysician profile
Connor Nathe
NPI 1770044752
$1,006.11
in general payments reported to CMS, 2019-2025
11 companies · $303 in 2025
The $303 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $129 · 2023: $210 · 2024: $364 · 2025: $303.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $877.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $876.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $398.82 | 2023-2025 | Clareon, Hydrus Microstent, Clareon Panoptix Pro |
| Apellis Pharmaceuticals, INC. | $129.46 | 2022 | |
| Sight Sciences, INC. | $91.51 | 2024 | Omni Surgical System |
| Rxsight INC | $90.63 | 2023-2025 | Rxsight Injector Handpiece, Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
| Sandoz INC. | $57.78 | 2024 | Cimerli |
| Abbvie INC. | $57.18 | 2024 | |
| Biotissue Holdings INC. | $53.77 | 2024-2025 | |
| Rayner Intraocular Lenses Limited | $36.04 | 2025 | Rayone Spheric, Rayner Cataract Set 1, Rayone Emv |
| Amgen INC. | $32.99 | 2024-2025 | Tepezza |
| Johnson & Johnson Surgical Vision, INC. | $29.79 | 2024 | Tecnis Iol |
| Tarsus Pharmaceuticals, INC. | $28.14 | 2025 | Xdemvy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Connor Nathe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.